In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…

Amidst the atmosphere of SABCS 2023, and at the center was Yara Abdou, MD, a…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…